scholarly article | Q13442814 |
P50 | author | Lawrence Carin | Q44654385 |
Stephen F Kingsmore | Q47815897 | ||
Jennifer C van Velkinburgh | Q55186605 | ||
Angela J Rogers | Q57319406 | ||
Vance G Fowler | Q63144471 | ||
Augustine M K Choi | Q114342087 | ||
P2093 | author name string | Christopher W Woods | |
G Ralph Corey | |||
David R Nelson | |||
Mu Wang | |||
Bo Chen | |||
Ephraim L Tsalik | |||
Geoffrey S Ginsburg | |||
Raymond J Langley | |||
Rebecca M Baron | |||
Charles B Cairns | |||
Seth W Glickman | |||
M Arthur Moseley | |||
Emanuel P Rivers | |||
Ronny M Otero | |||
Arturo Suarez | |||
J Will Thompson | |||
Carol J Saunders | |||
Darrell L Dinwiddie | |||
Neil A Miller | |||
Jacob Wulff | |||
Chunping Wang | |||
Laura E Fredenburgh | |||
Jinsam You | |||
Anthony F Massaro | |||
Robert P Mohney | |||
Lee Gazourian | |||
Brandon J Rice | |||
Brian Grinnell | |||
Debra H Freeman | |||
Brian T Edmonds | |||
Sarah S Soden | |||
Stephanie Reisinger | |||
P2860 | cites work | Dysregulation of mitochondrial dynamics and the muscle transcriptome in ICU patients suffering from sepsis induced multiple organ failure | Q21144214 |
Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine | Q22306067 | ||
Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression | Q24654019 | ||
HMDB: a knowledgebase for the human metabolome | Q24655295 | ||
A general introduction to the biochemistry of mitochondrial fatty acid β-oxidation | Q26699142 | ||
Transcriptional integration of mitochondrial biogenesis | Q26998468 | ||
Organization of GC/MS and LC/MS metabolomics data into chemical libraries | Q27702050 | ||
Early goal-directed therapy in the treatment of severe sepsis and septic shock | Q27860596 | ||
A comparison of normalization methods for high density oligonucleotide array data based on variance and bias | Q27860710 | ||
Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care | Q27860820 | ||
A statistical model for identifying proteins by tandem mass spectrometry | Q28186251 | ||
Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search | Q28211385 | ||
Therapeutic effects of lysophosphatidylcholine in experimental sepsis | Q28238163 | ||
Peroxisome proliferator-activated receptor alpha target genes | Q28248222 | ||
APACHE II: a severity of disease classification system | Q29547729 | ||
Efficacy and safety of recombinant human activated protein C for severe sepsis | Q29547839 | ||
Circulating mitochondrial DAMPs cause inflammatory responses to injury | Q29614470 | ||
TANDEM: matching proteins with tandem mass spectra | Q29615238 | ||
Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008 | Q29615602 | ||
A network-based analysis of systemic inflammation in humans | Q29617040 | ||
The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine | Q29618869 | ||
The pathophysiology and treatment of sepsis | Q29619103 | ||
Method to correlate tandem mass spectra of modified peptides to amino acid sequences in the protein database | Q30014825 | ||
Enteral omega-3 fatty acid, gamma-linolenic acid, and antioxidant supplementation in acute lung injury | Q30417223 | ||
A simplified procedure for the reduction and alkylation of cysteine residues in proteins prior to proteolytic digestion and mass spectral analysis | Q33206513 | ||
Genomic convergence analysis of schizophrenia: mRNA sequencing reveals altered synaptic vesicular transport in post-mortem cerebellum | Q33382735 | ||
Integrated, nontargeted ultrahigh performance liquid chromatography/electrospray ionization tandem mass spectrometry platform for the identification and relative quantification of the small-molecule complement of biological systems | Q33485414 | ||
A prospective study of the sensitivity, specificity and diagnostic performance of soluble intercellular adhesion molecule 1, highly sensitive C-reactive protein, soluble E-selectin and serum amyloid A in the diagnosis of neonatal infection | Q33557752 | ||
Analysis of factorial time-course microarrays with application to a clinical study of burn injury | Q33579870 | ||
Multiplex PCR to diagnose bloodstream infections in patients admitted from the emergency department with sepsis | Q33614220 | ||
Repeatability and reproducibility in proteomic identifications by liquid chromatography-tandem mass spectrometry | Q33639352 | ||
Succinate is an inflammatory signal that induces IL-1β through HIF-1α. | Q33652731 | ||
Fall in circulating mononuclear cell mitochondrial DNA content in human sepsis | Q33666825 | ||
Metabolic acidosis in patients with severe sepsis and septic shock: a longitudinal quantitative study. | Q43249641 | ||
Fibrinolytic and procoagulant activity in septic and haemorrhagic shock | Q43536523 | ||
Association between mitochondrial dysfunction and severity and outcome of septic shock | Q44074137 | ||
Altered expression of nuclear hormone receptors and coactivators in mouse heart during the acute-phase response | Q44710445 | ||
Initiation of inappropriate antimicrobial therapy results in a fivefold reduction of survival in human septic shock. | Q44877949 | ||
Performance of the modification of diet in renal disease and Cockcroft-Gault equations in the estimation of GFR in health and in chronic kidney disease | Q45198991 | ||
The late Na+ current (INa) inhibitor ranolazine attenuates effects of palmitoyl-L-carnitine to increase late INa and cause ventricular diastolic dysfunction. | Q46031511 | ||
Suppression of estrogen-related receptor alpha and medium-chain acyl-coenzyme A dehydrogenase in the acute-phase response | Q46238817 | ||
Toll-like receptor 4 mediates mitochondrial DNA damage and biogenic responses after heat-inactivated E. coli | Q46580770 | ||
Multiorgan failure is an adaptive, endocrine-mediated, metabolic response to overwhelming systemic inflammation | Q47944753 | ||
Estimating the statistical significance of peptide identifications from shotgun proteomics experiments. | Q51034842 | ||
Impaired energy metabolism in hearts of septic baboons: diminished activities of Complex I and Complex II of the mitochondrial respiratory chain. | Q51457168 | ||
Current epidemiology of septic shock: the CUB-Réa Network. | Q53924344 | ||
Protective role of peroxisome proliferator-activated receptor-β/δ in septic shock. | Q54657506 | ||
Plasma ceramide and lysophosphatidylcholine inversely correlate with mortality in sepsis patients | Q57375076 | ||
Biospecimen reporting for improved study quality (BRISQ) | Q57419587 | ||
Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction | Q57773627 | ||
Respiratory quotient and patterns of substrate utilization in human sepsis and trauma | Q70438175 | ||
Comprehensive label-free method for the relative quantification of proteins from biological samples | Q81012916 | ||
Hypotension and mortality in septic shock: the "golden hour" | Q83820319 | ||
Severe sepsis and septic shock. Definitions, epidemiology, and clinical manifestations | Q33893291 | ||
Metabolomic profiling can predict which humans will develop liver dysfunction when deprived of dietary choline | Q34017163 | ||
Host-response biomarkers for diagnosis of late-onset septicemia and necrotizing enterocolitis in preterm infants. | Q34028660 | ||
Peroxisome proliferator-activated receptor {delta} regulates inflammation via NF-{kappa}B signaling in polymicrobial sepsis | Q34162399 | ||
Regulation of mitochondrial processes by protein S-nitrosylation | Q34170269 | ||
Survival in critical illness is associated with early activation of mitochondrial biogenesis | Q34172119 | ||
Oxygen consumption and resting metabolic rate in sepsis, sepsis syndrome, and septic shock. | Q34350512 | ||
Energy balance and carbohydrate metabolism in infection and sepsis | Q34404359 | ||
Septic shock: an analysis of outcomes for patients with onset on hospital wards versus intensive care units. | Q34472809 | ||
Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on "sepsis-related problems" of the European Society of Intensive Care Medicine. | Q34480866 | ||
Genetics. Getting closer to the whole picture. | Q34623402 | ||
Disease progression in hemodynamically stable patients presenting to the emergency department with sepsis | Q34820224 | ||
Such stuff as dreams are made on: mediator-directed therapy in sepsis | Q35128911 | ||
Outcomes of patients undergoing early sepsis resuscitation for cryptic shock compared with overt shock. | Q35231436 | ||
Advances and challenges in liquid chromatography-mass spectrometry-based proteomics profiling for clinical applications | Q35610017 | ||
Reduced peroxisome proliferator-activated receptor α expression is associated with decreased survival and increased tissue bacterial load in sepsis | Q35680924 | ||
Inflammasome-regulated cytokines are critical mediators of acute lung injury | Q36026253 | ||
Biomarkers of inflammation, immunosuppression and stress with active disease are revealed by metabolomic profiling of tuberculosis patients | Q36109720 | ||
LPS decreases fatty acid oxidation and nuclear hormone receptors in the kidney | Q36870559 | ||
Identification of diagnostic biomarkers for infection in premature neonates | Q36919978 | ||
Recent developments in the diagnosis and management of severe sepsis | Q37031773 | ||
Discriminative value of inflammatory biomarkers for suspected sepsis | Q37086586 | ||
Management of sepsis: early resuscitation | Q37309588 | ||
Infection decreases fatty acid oxidation and nuclear hormone receptors in the diaphragm | Q37337481 | ||
Adult presentations of medium-chain acyl-CoA dehydrogenase deficiency (MCADD). | Q37612969 | ||
Sepsis biomarkers: a review | Q37689825 | ||
Serum lactate is a better predictor of short-term mortality when stratified by C-reactive protein in adult emergency department patients hospitalized for a suspected infection | Q37812755 | ||
Biomarkers: the future | Q37858113 | ||
Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients | Q39487652 | ||
Analysis of the adult human plasma metabolome | Q40107287 | ||
National Hospital Ambulatory Medical Care Survey: 2004 emergency department summary. | Q40474545 | ||
Mitochondrial dysfunction in a long-term rodent model of sepsis and organ failure | Q40551073 | ||
PPARalpha gene expression in the developing rat kidney: role of glucocorticoids | Q40803441 | ||
Postoperative hemostatic profile in relation to gram-negative septicemia. | Q40844846 | ||
Effect of hypoxia on pig heart short-chain acylcarnitines | Q42000926 | ||
Mitochondrial biogenesis restores oxidative metabolism during Staphylococcus aureus sepsis | Q42015474 | ||
The systemic inflammatory response syndrome (SIRS) to identify infected patients in the emergency room | Q42035221 | ||
Acetyl-L-carnitine supplementation differently influences nutrient partitioning, serum leptin concentration and skeletal muscle mitochondrial respiration in young and old rats | Q42519566 | ||
P433 | issue | 195 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | sepsis | Q183134 |
P304 | page(s) | 195ra95 | |
P577 | publication date | 2013-07-01 | |
P1433 | published in | Science Translational Medicine | Q1573955 |
P1476 | title | An integrated clinico-metabolomic model improves prediction of death in sepsis | |
P478 | volume | 5 |
Q89783351 | 1H NMR Based Metabolomics in Human Sepsis and Healthy Serum |
Q64068179 | A host gene expression approach for identifying triggers of asthma exacerbations |
Q53821170 | An Innovative Approach for The Integration of Proteomics and Metabolomics Data In Severe Septic Shock Patients Stratified for Mortality. |
Q34762245 | An integrated transcriptome and expressed variant analysis of sepsis survival and death |
Q38204194 | Applying metabolomics to uncover novel biology in ARDS. |
Q58723478 | Association between 4-year all-cause mortality and carnitine profile in maintenance hemodialysis patients |
Q40191355 | Associations of Nasopharyngeal Metabolome and Microbiome with Severity Among Infants with Bronchiolitis: A Multi-omic Analysis |
Q55262082 | Associations of the plasma lipidome with mortality in the acute respiratory distress syndrome: a longitudinal cohort study. |
Q38277169 | Beyond single-nucleotide polymorphisms: genetics, genomics, and other 'omic approaches to acute respiratory distress syndrome |
Q40143144 | Biomarker candidates for the detection of an infectious etiology of febrile neutropenia |
Q21562282 | Biomarker profiling by nuclear magnetic resonance spectroscopy for the prediction of all-cause mortality: an observational study of 17,345 persons |
Q61448382 | Biomarkers for Acute Respiratory Distress syndrome and prospects for personalised medicine |
Q33778888 | Candidate genes on murine chromosome 8 are associated with susceptibility to Staphylococcus aureus infection in mice and are involved with Staphylococcus aureus septicemia in humans |
Q35807000 | Case report: severe reversible cardiomyopathy associated with systemic inflammatory response syndrome in the setting of diabetic hyperosmolar hyperglycemic non-ketotic syndrome. |
Q40075609 | Characterization of a metabolomic profile associated with responsiveness to therapy in the acute phase of septic shock. |
Q40503612 | Combining Biomarkers with EMR Data to Identify Patients in Different Phases of Sepsis. |
Q89771031 | Contemporary strategies to improve clinical trial design for critical care research: insights from the First Critical Care Clinical Trialists Workshop |
Q58697850 | Cross-Talk Between Iron and Glucose Metabolism in the Establishment of Disease Tolerance |
Q42021702 | Deletion of Pim kinases elevates the cellular levels of reactive oxygen species and sensitizes to K-Ras-induced cell killing. |
Q89974259 | Derivation of a metabolic signature associated with bacterial meningitis in infants |
Q90023468 | Development of an Algorithm to Predict Mortality in Patients With Sepsis and Coagulopathy |
Q36070766 | Differential expression of the Nrf2-linked genes in pediatric septic shock. |
Q92377506 | Differential gene expression analysis reveals novel genes and pathways in pediatric septic shock patients |
Q34692311 | Discrimination of sepsis stage metabolic profiles with an LC/MS-MS-based metabolomics approach |
Q27325556 | Dusp3 and Psme3 are associated with murine susceptibility to Staphylococcus aureus infection and human sepsis |
Q38669814 | Early Diagnosis of Sepsis: Is an Integrated Omics Approach the Way Forward? |
Q36927395 | Efficacy and Safety of Glutamine-supplemented Parenteral Nutrition in Surgical ICU Patients: An American Multicenter Randomized Controlled Trial. |
Q48249825 | Emerging Biomarkers of Illness Severity: Urinary Metabolites Associated with Sepsis and Necrotizing Methicillin-Resistant Staphylococcus aureus Pneumonia |
Q57922233 | Energy Demands of Early Life Drive a Disease Tolerant Phenotype and Dictate Outcome in Neonatal Bacterial Sepsis |
Q34102154 | Energy crisis: the role of oxidative phosphorylation in acute inflammation and sepsis |
Q38749799 | Enhanced understanding of the host-pathogen interaction in sepsis: new opportunities for omic approaches. |
Q93172729 | Epigenetic and metabolic programming of innate immunity in sepsis |
Q59127229 | Evaluating the discriminating capacity of cell death (apoptotic) biomarkers in sepsis |
Q37681186 | Exogenous l-Valine Promotes Phagocytosis to Kill Multidrug-Resistant Bacterial Pathogens. |
Q36275860 | Expression of genes belonging to the interacting TLR cascades, NADPH-oxidase and mitochondrial oxidative phosphorylation in septic patients |
Q33584763 | Extensive alterations of blood metabolites in pediatric cerebral malaria |
Q27687323 | From data patterns to mechanistic models in acute critical illness. |
Q40210673 | Generalizable Biomarkers in Critical Care: Toward Precision Medicine |
Q99608040 | Global proteome and phosphoproteome characterization of sepsis-induced kidney injury |
Q26801681 | Hemopexin and haptoglobin: allies against heme toxicity from hemoglobin not contenders |
Q64111485 | Heterogeneity in sepsis: new biological evidence with clinical applications |
Q33828992 | Honing in on enteric fever |
Q36998590 | Host gene expression classifiers diagnose acute respiratory illness etiology |
Q37688733 | Human genetic and metabolite variation reveals that methylthioadenosine is a prognostic biomarker and an inflammatory regulator in sepsis |
Q35247557 | Human metabolic response to systemic inflammation: assessment of the concordance between experimental endotoxemia and clinical cases of sepsis/SIRS. |
Q59807396 | Hydrocortisone, Ascorbic Acid and Thiamine (HAT Therapy) for the Treatment of Sepsis. Focus on Ascorbic Acid |
Q42512567 | IL-7 Restores T Lymphocyte Immunometabolic Failure in Septic Shock Patients through mTOR Activation. |
Q92264971 | Immune Response Resetting in Ongoing Sepsis |
Q91124813 | Immunometabolic approaches to prevent, detect, and treat neonatal sepsis |
Q112290940 | Immunometabolic signatures predict risk of progression to sepsis in COVID-19 |
Q38152236 | Immunopathogenesis of abdominal sepsis |
Q34436487 | Improved drug therapy: triangulating phenomics with genomics and metabolomics. |
Q33427877 | Improvement of prognostic performance in severely injured patients by integrated clinico-transcriptomics: a translational approach |
Q33411767 | Inducing host protection in pneumococcal sepsis by preactivation of the Ashwell-Morell receptor |
Q35122587 | Integration of metabolic and inflammatory mediator profiles as a potential prognostic approach for septic shock in the intensive care unit |
Q34425990 | Integrative "omic" analysis of experimental bacteremia identifies a metabolic signature that distinguishes human sepsis from systemic inflammatory response syndromes |
Q38429229 | Integrative model of leukocyte genomics and organ dysfunction in heart failure patients requiring mechanical circulatory support: a prospective observational study |
Q48194956 | Intensive care medicine in 2050: precision medicine |
Q36424765 | Judging quality of current septic shock definitions and criteria |
Q37684850 | Lipid Use and Misuse by the Heart. |
Q38165517 | Lipid mediators in immune dysfunction after severe inflammation |
Q40702828 | Lipid metabolites as potential diagnostic and prognostic biomarkers for acute community acquired pneumonia |
Q37662755 | Lipid response patterns in acute phase paediatric Plasmodium falciparum malaria |
Q34091261 | Long term conservation of human metabolic phenotypes and link to heritability |
Q37656058 | MKK3 regulates mitochondrial biogenesis and mitophagy in sepsis-induced lung injury. |
Q39139022 | Mass spectrometry for the discovery of biomarkers of sepsis |
Q30654390 | Metabolic Profiling of Children Undergoing Surgery for Congenital Heart Disease |
Q90166360 | Metabolic support in the critically ill: a consensus of 19 |
Q61783676 | Metabolic systems analysis of LPS induced endothelial dysfunction applied to sepsis patient stratification |
Q38845332 | Metabolism, Metabolomics, and Nutritional Support of Patients with Sepsis. |
Q64100710 | Metabolite Profiles of the Cerebrospinal Fluid in Neurosyphilis Patients Determined by Untargeted Metabolomics Analysis |
Q59791316 | Metabolite changes in blood predict the onset of tuberculosis |
Q45964993 | Metabolites Associated With Malnutrition in the Intensive Care Unit Are Also Associated With 28-Day Mortality. |
Q35901678 | Metabolites in Blood for Prediction of Bacteremic Sepsis in the Emergency Room |
Q37534631 | Metabolomic derangements are associated with mortality in critically ill adult patients |
Q39386206 | Metabolomics as a Driver in Advancing Precision Medicine in Sepsis. |
Q26764983 | Metabonomics and intensive care |
Q51167691 | Mitochondrial DNA Damage Initiates Acute Lung Injury and Multi-Organ System Failure Evoked in Rats by Intra-Tracheal Pseudomonas Aeruginosa. |
Q37739000 | Mitochondrial Dysfunction and Immune Cell Metabolism in Sepsis. |
Q38286512 | Molecular diagnosis of sepsis: New aspects and recent developments |
Q57117292 | Molecular signatures of liver dysfunction are distinct in fungal and bacterial infections in mice |
Q27352616 | Mortality prediction in patients with severe septic shock: a pilot study using a target metabolomics approach |
Q41513678 | Multiplexed separations for biomarker discovery in metabolomics: Elucidating adaptive responses to exercise training. |
Q35669404 | N-lactoyl-amino acids are ubiquitous metabolites that originate from CNDP2-mediated reverse proteolysis of lactate and amino acids |
Q33804385 | Neonatal Meningitis: Overcoming Challenges in Diagnosis, Prognosis, and Treatment with Omics |
Q26800283 | New approaches to understanding the immune response to vaccination and infection |
Q90319470 | New markers for sepsis caused by Pseudomonas aeruginosa during burn infection |
Q37238202 | New paradigms in sepsis: from prevention to protection of failing microcirculation |
Q47292048 | Nutritional metabolomics in critical illness. |
Q40545879 | Opposing Effects of Fasting Metabolism on Tissue Tolerance in Bacterial and Viral Inflammation |
Q35104183 | Oxidants in Acute and Chronic Lung Disease |
Q90108849 | PKCδ causes sepsis-induced cardiomyopathy by inducing mitochondrial dysfunction |
Q26771753 | PPARs: Protectors or Opponents of Myocardial Function? |
Q90703154 | Pathological alteration and therapeutic implications of sepsis-induced immune cell apoptosis |
Q33439759 | Pathophysiology of Pediatric Multiple Organ Dysfunction Syndrome |
Q35761448 | Pathophysiology of sepsis-related cardiac dysfunction: driven by inflammation, energy mismanagement, or both? |
Q36803427 | Peptidomic Analysis of Rat Plasma: Proteolysis in Hemorrhagic Shock |
Q62490440 | Peripheral blood RNA gene expression in children with pneumococcal meningitis: a prospective case-control study |
Q35127737 | Pharmacometabolomics of l-carnitine treatment response phenotypes in patients with septic shock. |
Q36055457 | Plasma metabolomic profiles enhance precision medicine for volunteers of normal health |
Q90727665 | Plasma metabolomics and clinical predictors of survival differences in COPD patients |
Q33582467 | Plasma metabolomics for the diagnosis and prognosis of H1N1 influenza pneumonia |
Q91891985 | Plasma metabolomics of early parenteral nutrition followed with enteral nutrition in pancreatic surgery patients |
Q60926108 | Plasma mitochondrial DNA and metabolomic alterations in severe critical illness |
Q59809030 | Potential therapy strategy: targeting mitochondrial dysfunction in sepsis |
Q91928793 | Prediction of sepsis mortality using metabolite biomarkers in the blood: a meta-analysis of death-related pathways and prospective validation |
Q59218360 | Predictive biomarkers and metabolic hallmark of postoperative hypoxaemia |
Q90069519 | Prognostic and predictive enrichment in sepsis |
Q47398299 | Proteomic study revealed cellular assembly and lipid metabolism dysregulation in sepsis secondary to community-acquired pneumonia. |
Q58792292 | Pyruvate dehydrogenase complex stimulation promotes immunometabolic homeostasis and sepsis survival |
Q38724278 | Recent developments in severe sepsis research: from bench to bedside and back |
Q26851729 | Regulation of mitochondrial biogenesis and its intersection with inflammatory responses |
Q36113202 | Renal systems biology of patients with systemic inflammatory response syndrome |
Q89433986 | Reprogramming of basic metabolic pathways in microbial sepsis: therapeutic targets at last? |
Q47728125 | Review article: Sepsis in the emergency department - Part 2: Investigations and monitoring. |
Q33829003 | Salmonella Typhi and Salmonella Paratyphi A elaborate distinct systemic metabolite signatures during enteric fever |
Q38669414 | Sepsis reconsidered: Identifying novel metrics for behavioral landscape characterization with a high-performance computing implementation of an agent-based model |
Q58758376 | Sepsis: Personalized Medicine Utilizing 'Omic' Technologies-A Paradigm Shift? |
Q38453261 | Sepsis: a roadmap for future research |
Q92757558 | Sepsis: personalization v protocolization? |
Q49561103 | Septic Shock Non-Survivors have Persistently Elevated Acylcarnitines Following Carnitine Supplementation. |
Q26797235 | Septic Shock: Advances in Diagnosis and Treatment |
Q34801529 | Sequential actions of SIRT1-RELB-SIRT3 coordinate nuclear-mitochondrial communication during immunometabolic adaptation to acute inflammation and sepsis. |
Q47136454 | Seven unconfirmed ideas to improve future ICU practice. |
Q26765202 | Sharpening Precision Medicine by a Thorough Interrogation of Metabolic Individuality |
Q58742374 | Sirtuins and Immuno-Metabolism of Sepsis |
Q33442820 | Survival, bacterial clearance and thrombocytopenia are improved in polymicrobial sepsis by targeting nuclear transport shuttles. |
Q38854820 | Systematic Molecular Phenotyping: A Path Toward Precision Emergency Medicine? |
Q112281948 | Systemic inflammation and metabolic disturbances underlie inpatient mortality among ill children with severe malnutrition |
Q113240435 | The Childhood Acute Illness and Nutrition (CHAIN) network nested case-cohort study protocol: a multi-omics approach to understanding mortality among children in sub-Saharan Africa and South Asia |
Q26768286 | The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) |
Q28079517 | The diagnostic and prognostic value of systems biology research in major traumatic and thermal injury: a review |
Q35673576 | The kinase Jnk2 promotes stress-induced mitophagy by targeting the small mitochondrial form of the tumor suppressor ARF for degradation |
Q40060019 | The oxylipin and endocannabidome responses in acute phase Plasmodium falciparum malaria in children |
Q50232699 | The road to precision medicine in sepsis: blood transcriptome endotypes. |
Q47662026 | The role of metabolomic markers for patients with infectious diseases: implications for risk stratification and therapeutic modulation |
Q38261764 | The simultaneous occurrence of both hypercoagulability and hypofibrinolysis in blood and serum during systemic inflammation, and the roles of iron and fibrin(ogen). |
Q36509516 | The systemic immune response to trauma: an overview of pathophysiology and treatment |
Q58763552 | Time course of liver mitochondrial function and intrinsic changes in oxidative phosphorylation in a rat model of sepsis |
Q35056779 | UCP2-induced fatty acid synthase promotes NLRP3 inflammasome activation during sepsis |
Q37668704 | Understanding Physiology in the Continuum: Integration of Information from Multiple -Omics Levels |
Q52656196 | Unsupervised Analysis of Transcriptomics in Bacterial Sepsis Across Multiple Datasets Reveals Three Robust Clusters. |
Q92518997 | Untargeted Metabolomics Differentiates l-Carnitine Treated Septic Shock 1-Year Survivors and Nonsurvivors |
Q30376327 | What was old is new again: using the host response to diagnose infectious disease. |
Q35957668 | Whole Blood Reveals More Metabolic Detail of the Human Metabolome than Serum as Measured by 1H-NMR Spectroscopy: Implications for Sepsis Metabolomics. |
Search more.